Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Mitochondrial dysfunction is linked to long-term toxicities from human immunodeficiency virus (HIV) therapy.
• Nucleoside analog reverse transcriptase inhibitors (NRTIs) are a class of antiretroviral drugs frequently implicated in mitochondrial toxicity.
• Observed toxicities include lactic acidosis, hepatic steatosis, myopathies, cardiomyopathies, neuropathies, and lipodystrophy.

Purpose of the Study:

• To critically examine the scientific evidence associating mitochondrial dysfunction with antiretroviral therapies, specifically NRTIs.
• To investigate the potential causal role of mitochondrial dysfunction in NRTI-associated toxicities in HIV-infected patients.

Main Methods:

• Review of existing scientific literature.
• Examination of data from human studies.
• Analysis of animal model studies.
• Evaluation of in vitro experimental data.

Main Results:

• Evidence suggests a correlation between NRTI use and mitochondrial dysfunction.
• Mitochondrial toxicity is a proposed mechanism for various adverse effects associated with NRTIs.
• Data from human, animal, and in vitro studies support this association.

Conclusions:

• Mitochondrial dysfunction is implicated as a causal factor in NRTI-associated toxicities in HIV patients.
• Understanding this link is crucial for managing long-term HIV therapy success.
• Further research is warranted to elucidate the precise mechanisms and develop mitigating strategies.